In a stunning blow to one of the world’s most valuable companies, a U.S. jury has ordered Apple to pay Masimo a staggering $634 million in a high-stakes patent dispute over smartwatch technology. But here’s where it gets controversial: this isn’t just about money—it’s about innovation, intellectual property, and allegations of corporate espionage. Could this case redefine how tech giants protect—or poach—cutting-edge ideas? Let’s dive in.
Imagine walking into an Apple Store in New York City in 2025, where rows of sleek Apple Watches gleam under the lights. These devices, beloved by millions, are now at the center of a legal storm. On November 14, a federal jury in California ruled that Apple infringed on a patent held by Masimo, a medical-monitoring technology company, specifically related to blood-oxygen reading technology. The jury found that the Apple Watch’s workout mode and heart rate notification features violated Masimo’s intellectual property rights, a claim Masimo has fiercely defended.
But this is the part most people miss: This $634 million verdict is just one battle in a much larger, multi-front war. Masimo has accused Apple of not only stealing its pulse oximetry technology but also recruiting its employees to gain an unfair advantage. This dispute escalated in 2023 when a U.S. trade tribunal banned imports of Apple’s Series 9 and Ultra 2 smartwatches, forcing Apple to temporarily remove the blood-oxygen feature from its watches. Apple later reintroduced an updated version of the technology in August 2025, but the fight is far from over.
Apple, unsurprisingly, disagrees with the verdict and plans to appeal. In a statement, Masimo hailed the decision as “a significant win in our ongoing efforts to protect our innovations and intellectual property.” Yet, the saga continues: the International Trade Commission (ITC) is now considering whether Apple’s updated watches should face another import ban, while Masimo has sued U.S. Customs over its approval of Apple’s modified devices. Meanwhile, Apple has challenged the ban in a federal appeals court, and a separate trade-secret case between the two companies ended in a mistrial in 2023.
To add another layer of complexity, Apple scored a minor victory in Delaware last year, winning a $250 verdict against Masimo over alleged design patent infringements in Masimo’s smartwatches. This back-and-forth raises a critical question: Are tech giants like Apple playing fair when it comes to innovation, or is this just the cost of doing business in a cutthroat industry?
For beginners, patent disputes like this can seem overwhelming, but at their core, they’re about protecting ideas. Patents give inventors exclusive rights to their creations for a limited time, encouraging innovation by ensuring they can profit from their work. When companies like Apple and Masimo clash, it’s not just about money—it’s about who gets to claim ownership of life-changing technology.
Here’s the controversial question we’re left with: Is Apple’s dominance in the tech industry stifling smaller innovators like Masimo, or is this simply a case of a company defending its turf in a highly competitive market? Let us know your thoughts in the comments—this debate is far from settled.
